Long-term Persistence of Immunity Against Hepatitis B in 7-8 Years Old Children After Hepatitis B Vaccination.

Clinical trial NCT00519649 · COMPLETED

Trial details

NCT number: NCT00519649
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hepatitis B Vaccine

Start date: 2007-08-31
Primary completion: 2007-12-31
Enrollment: 301

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.